Becoming a solo entrepreneur in the years between leaving an employer and claiming Social Security can give your savings a boost. Here’s what to know.
Category: Health Insurance and Managed Care
-
Corporate Giants Buy Up Primary Care Practices at Rapid Pace
Large health insurers and other companies are especially keen on doctors’ groups that care for patients in private Medicare plans.
-
Kaiser Permanente to Acquire Geisinger
The California health care organization will create a new nonprofit that aims to acquire a half-dozen additional community health systems.
-
Insurers Are Starting to Cover Telehealth Abortion
Several insurers will cover abortions through Hey Jane, a start-up online provider, just as courts threaten to hobble the industry.
-
As Mental Health Crisis Grows, More Doors Open to Care
Developers are working with health care providers to add psychiatric hospitals, addiction recovery centers and other behavioral health clinics.
-
Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.
The New York Times – Business:A ruling by a federal judge this week could set up yet another Supreme Court challenge to the Obamacare health law.
-
Medicare Delays a Full Crackdown on Private Health Plans
The New York Times – Business:After intense lobbying by insurers, U.S. health officials say curbs aimed at overbilling by Medicare Advantage will be eased in over 3 years.
-
Medicare Tries to Combat Fraud. Now Insurers Are Fighting Back.
The New York Times – Business:The Biden administration has proposed changes to how it would pay private Medicare Advantage plans, setting off a lobbying frenzy.
-
Biden Warns That Climate Change Could Upend Federal Spending Programs
The New York Times – Business:A chapter in the new Economic Report of the President focuses on the growing risks to people and businesses from rising temperatures, and the government’s role in adapting to them.
-
Sanofi Plans to Cut the Price of Insulin
The New York Times – Business:The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.